Results 191 to 200 of about 12,522 (293)

Sweat chloride reflects CFTR function and correlates with clinical outcomes following CFTR modulator treatment

Edith T. Zemanick, Bonnie W. Ramsey, Dorota Sands, Edward F. McKone, Isabelle Fajac, Jennifer L. Taylor‐Cousar, Marcus Mall, Michael W. Konstan, Nitin Nair, Jesse Zhu, Emilio Arteaga‐Solis, Fredrick Van Goor, Lisa J. McGarry, Valentin Prieto-Centurion, Patrick R. Sosnay, Carmen Bozic, David Waltz, Nicole Mayer-Hamblett   +17 more
openalex   +1 more source

Code supporting "Phenotyping ciliary dynamics and coordination in response to CFTR-modulators in Cystic Fibrosis respiratory epithelial cells"

, 2019
Luigi Feriani, Pietro Cicuta
openalex   +1 more source

Breaking boundaries or a small piece of the puzzle: can CFTR modulators transform bronchiectasis care? [PDF]

ERJ Open Res
Graeber SY, Frost F.
europepmc   +1 more source

WS12.2 Evolution of inflammatory parameters during CFTR-modulator therapy with lumacaftor/ivacaftor in children aged 6 to 12 years

, 2021
Jochen Rößler, Rebecca L. Knoll, S. Wirsching, Maximiliano L. Cacicedo, Peter Mildenberger, Sonja Gehring, Oliver Nitsche, Krystyna Poplawska   +7 more
openalex   +1 more source

Cystic fibrosis-related diabetes in the era of modern treatment using CFTR modulators in pediatric patients-a systematic review. [PDF]

Front Pediatr
Pietrzykowska A, Darmoń J, Szymocha K, Donocik W, Tarasiewicz M, Stadnik J, Jarosz-Chobot P.   +6 more
europepmc   +1 more source

Functional evaluation of the CFTR activity of the Dele2-, Dele2,3- and Dele13-CFTR mutants on a heterologous expression system after treatment with pharmacological modulators.

Cristina Pastorino (20277087), Ludovica Menta (22258367), Emanuela Pesce (207804), Mariateresa Lena (20277090), Valeria Tomati (6080210), Valeria Capurro (282901), Marco Di Duca (11801237), Vito Terlizzi (5564168), Andrea Gramegna (5890742), Francesco Blasi (61418), Carlo Castellani (724942), Serena Cappato (115162), Federico Zara (176248), Nicoletta Pedemonte (383764), Renata Bocciardi (115174)   +14 more
openalex   +1 more source

CFTR modulator therapy for cystic fibrosis caused by the rare c.3700A>G mutation

, 2020
Puay‐Wah Phuan, Peter M. Haggie, Joseph Tan, Amber A. Rivera, Walter E. Finkbeiner, Dennis W. Nielson, Merlin Thomas, Ibrahim A. Janahi, A. S. Verkman   +8 more
openalex   +2 more sources

Evolving Cystic Fibrosis Care: Lung Immunology and Emerging Health Challenges in the Era of CFTR Modulators. [PDF]

Biomolecules
Parisi GF, Papale M, Pecora G, Presti S, Tosto M, Mulé E, Ornato V, Aloisio D, Leonardi S.   +8 more
europepmc   +1 more source

Targeting cystic fibrosis inflammation in the age of CFTR modulators: focus on macrophages [PDF]

, 2020
Jonathan L. Gillan, Donald J. Davidson, Robert D. Gray   +2 more
openalex   +1 more source

Post-approval studies with the CFTR modulators Elexacaftor-Tezacaftor-Ivacaftor. [PDF]

Front Pharmacol, 2023
Tümmler B.
europepmc   +1 more source